Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Old MAV Wind-Down Ltd. Regulatory Filings 2021

Mar 31, 2021

47603_rns_2021-03-31_22439f70-6cc6-4482-97c4-7a523bbbaa1d.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE

MANAGEMENT CERTIFICATION

I, Keith Strachan, an officer of the reporting issuer noted below have examined this Form 13-501F1 (the Form ) being submitted hereunder to the Alberta Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is complete and accurate.

(signed) “Keith Strachan” March 31, 2021 Name: Keith Strachan Date Title: Interim CEO

Reporting Issuer Name: MediPharm Labs Corp. End date of previous financial year: 31/12/2020 Type of Reporting Issuer: Class 1 reporting issuer Class 3B reporting issuer Highest Trading Marketplace: Toronto Stock Exchange

Market value of listed or quoted equity securities:

==> picture [470 x 215] intentionally omitted <==

----- Start of picture text ----- Equity Symbol LABS1 [st] Specified Trading Period (dd/mm/yy) 01/01/2020 to 31/03/2020Closing price of the security in the class or series onthe last trading day of the specified trading period inwhich such security was listed or quoted on thehighest trading marketplace $ 1.59(i)Number of securities in the class or series of suchsecurity outstanding at the end of the last tradingday of the specified trading period 134,723,297(ii)Market value of class or series (i) x (ii) $ 214,210,042(A)----- End of picture text -----

01/04/2020 to 30/06/2020

2[nd] Specified Trading Period (dd/mm/yy)

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

==> picture [470 x 523] intentionally omitted <==

----- Start of picture text ----- highest trading marketplace $ 1.15(iii)Number of securities in the class or series of suchsecurity outstanding at the end of the last tradingday of the specified trading period 136,277,016(iv)Market value of class or series (iii) x (iv) $ 156,718,568(B)3 [rd] Specified Trading Period (dd/mm/yy) 01/07/2020 to 30/09/2020Closing price of the security in the class or series onthe last trading day of the specified trading period inwhich such security was listed or quoted on thehighest trading marketplace $ 0.88(v)Number of securities in the class or series of suchsecurity outstanding at the end of the last tradingday of the specified trading period 139,590,283(vi)Market value of class or series (v) x (vi) $ 122,839,449(C)4 [th] Specified Trading Period (dd/mm/yy) 01/10/2020 to 31/12/2020Closing price of the security in the class or series onthe last trading day of the specified trading period inwhich such security was listed or quoted on thehighest trading marketplace $ 0.53(vii)Number of securities in the class or series of suchsecurity outstanding at the end of the last tradingday of the specified trading period 155,550,487(viii)Market value of class or series (vii) x (viii) $ 82,441,758(D)----- End of picture text -----

5[th] Specified Trading Period (dd/mm/yy)

N/A

to N/A

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

highest trading marketplace $ N/A
(ix)
Number of securities in the class or series of such
security outstanding at the end of the last trading
day of the specified trading period N/A
(x)
Market value of class or series (ix) x (x)$ N/A
(E)
Average Market Value of Class or Series
(Calculate the simple average of the market value of the class
or series of security for each applicable specified tradingperiod (i.e. A through E above)) $ 144,052,454
(1)
Repeat the above calculation for each other class or series of equity securities of the reporting iss
ubsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous fina
Fair value of outstanding debt securities:
(Provide details of how value was determined) $ N/A
(2)
Capitalization for the previous financial year (1) + (2)$ 144,052,454
Participation Fee $ 6,500
Late Fee, if applicable $
Total Fee Payable $ 6,500
(Participation Fee plus Late Fee)

(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year)